immune checkpoint inhibitors

Researchers have identified a gene biomarker associated with overall survival and treatment response in people with gastric cancer.

Adding mRNA therapy improves the response to cancer immunotherapy in people who weren't responding to the treatment, Mayo Clinic research shows.

A study by Mayo Clinic researchers finds that immune checkpoint inhibitors may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis.